Humira blood levels may predict RA outcomes, study finds
NCT ID NCT01382160
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 14 times
Summary
This study looked at 69 people with rheumatoid arthritis taking the drug adalimumab (Humira). Researchers measured drug levels in the blood over 6 months to see if they could predict how well the treatment would work. The goal was to find a way to adjust doses early, improving response and reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHR d'Orléans
Orléans, France
-
CHR du Mans
Le Mans, France
-
CHRU de Brest
Brest, France
-
CHRU de Nantes
Nantes, France
-
CHRU de Poitiers
Poitiers, France
-
CHRU de Rennes
Rennes, France
-
CHRU de Tours
Tours, France
Conditions
Explore the condition pages connected to this study.